As of Nov 27
| +0.30 / +0.90%|
The 29 analysts offering 12-month price forecasts for Roche have a median target of 39.05, with a high estimate of 45.87 and a low estimate of 30.12. The median estimate represents a +16.59% increase from the last price of 33.49.
The current consensus among 31 polled investment analysts is to Buy stock in Roche. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.